スポンサーリンク
Second Department of Internal Medicine Kurume University School of Medicine | 論文
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- A Case-Control Study on Male Hepatocellular Carcinoma Based on Hospital and Community Controls
- Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
- Liver-Associated Natural Killer Activity in Cirrhotic Rats
- Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
- Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels:A Comparison with Symptomatic Carriers
- Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma
- High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection
- Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area
- GASTRIC SCHWANNOMA WITH ADJACENT EXTERNAL PROGRESSION HARBORED ABERRANT NF2 GENE
- Bone morphogenetic protein 2 induced differentiation toward superficial epithelial cells in the gastric mucosa
- Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis
- Suppression of interleukin-1β- and tumor necrosis factor-α-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis
- Effect of germinated barley foodstuff administration on mineral utilization in rodents
- Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting
- Ligation plus low-volume sclerotherapy for high-risk esophageal varices : Comparisons with ligation therapy or sclerotherapy alone
- Influence of extravariceal collateral channel pattern on recurrence of esophageal varices after sclerotherapy
- Cronkhite-Canada Syndrome Associated with Advanced Rectal Cancer Treated by a Subtotal Colectomy : Report of a Case
- Association of HLA-DRB1 0803 and 1602 with the susceptibility to primary biliary cirrhosis
- Secretory IgA anti-HAV in bile of hepatitis A patients